Literature DB >> 2251909

Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of wallerian degeneration.

H Konno1, T Yamamoto, H Suzuki, H Yamamoto, Y Iwasaki, Y Ohara, H Terunuma, N Harata.   

Abstract

To clarify the implication of the major histocompatibility complex class II (Ia) antigen induction in microglia following Wallerian degeneration in the central nervous system (CNS), experimental allergic encephalitis (EAE) was adoptively transferred to Lewis rats in which Ia antigens had been induced in microglia at the sites of Wallerian degeneration. In addition to randomly distributed typical EAE lesions, the recipient rats developed distinct inflammatory lesions in accord with the distribution of Ia-positive microglia; i.e., in the ipsilateral thalamus after cortical cryoinjury, and in the ipsilateral optic nerve, the contralateral optic tract and superior colliculus after unilateral eye ball enucleation. Thus, the EAE locus may be targeted by this approach. The inflammatory response was inducible by transfer of myelin basic protein-stimulated lymphocytes but not by transfer of phytohemagglutinin-stimulated or non-stimulated lymphocytes. When examined using monoclonal antibody surface markers; OX-6 for Ia antigen, W3/13 for pan T lymphocyte and OX-8 for cytotoxic/suppresser T lymphocyte, the types of lymphocytes in these lesions did not differ from those in ordinary EAE lesions in the spinal cord. The potential role of non-immunologically induced Ia-positive cell clusters that serve as a target for autoimmune CNS diseases was discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251909     DOI: 10.1007/bf00294613

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons.

Authors:  J Maehlen; T Olsson; A Zachau; L Klareskog; K Kristensson
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

2.  [Permeability of the cerebral vessels. VI. Experimental demyelination produced by substances acting on the hemato-encephalic barrier].

Authors:  R Gonsette; G Andre-Balisaux; P Delmotte
Journal:  Acta Neurol Psychiatr Belg       Date:  1966-04

3.  Axonal degeneration induced by experimental noninvasive minor head injury.

Authors:  J A Jane; O Steward; T Gennarelli
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

4.  Pathologic-anatomical findings and cerebral localization in stereotactic treatment of extrapyramidal motor disturbances in multiple sclerosis.

Authors:  T Riechert; R Hassler; F Mundinger; F Bronisch; K Schmidt
Journal:  Confin Neurol       Date:  1975

5.  Intercellular interactions in myelin-specific autoimmunity.

Authors:  H Wekerle
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

6.  The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration.

Authors:  R A Sobel; B W Blanchette; A K Bhan; R B Colvin
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Sequelae of the osmotic blood-brain barrier opening in rats.

Authors:  M Suzuki; Y Iwasaki; T Yamamoto; H Konno; H Kudo
Journal:  J Neurosurg       Date:  1988-09       Impact factor: 5.115

8.  In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis. An immunohistochemical study.

Authors:  Y Matsumoto; M Fujiwara
Journal:  J Neuroimmunol       Date:  1986-10       Impact factor: 3.478

9.  On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation.

Authors:  U Traugott; L C Scheinberg; C S Raine
Journal:  J Neuroimmunol       Date:  1985-04       Impact factor: 3.478

10.  Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system.

Authors:  W J Streit; M B Graeber; G W Kreutzberg
Journal:  J Neuroimmunol       Date:  1989-02       Impact factor: 3.478

View more
  23 in total

1.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen.

Authors:  T Kuhlmann; A Bitsch; C Stadelmann; H Siebert; W Brück
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

3.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

4.  Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia.

Authors:  T Morioka; A N Kalehua; W J Streit
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 5.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

Authors:  Burkhard Becher; Ingo Bechmann; Melanie Greter
Journal:  J Mol Med (Berl)       Date:  2006-06-14       Impact factor: 4.599

6.  Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Emily Jane Terry; Robert S Fujinami
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 7.  Immune control of the brain.

Authors:  M Bradl
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

9.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

Review 10.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.